New York, NYCIK 20102044 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
11 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Roivant Sciences Ltd | 3.08M | $66.93M | 24.0% | −1.32M | Reduced |
| 2 | Diversified Healthcare Tr | 6.53M | $31.67M | 11.4% | +380.1K | Added |
| 3 | Privia Health Group Inc | 1.30M | $30.82M | 11.1% | +209.6K | Added |
| 4 | Niq Global Intelligence PLC |
| 1.80M |
| $29.68M |
| 10.6% |
| +1.80M |
| New |
| 5 | Nextera Energy Inc | 335.0K | $26.89M | 9.6% | +65.0K | Added |
| 6 | Mcgraw Hill Inc | 1.40M | $23.10M | 8.3% | +549.2K | Added |
| 7 | Amneal Pharmaceuticals Inc | 1.57M | $19.78M | 7.1% | −619.5K | Reduced |
| 8 | Viking Therapeutics Inc | 550.0K | $19.35M | 6.9% | +50.0K | Added |
| 9 | Cogent Communications Hldgs | 650.0K | $14.01M | 5.0% | +275.0K | Added |
| 10 | Arbutus Biopharma Corp | 1.85M | $8.90M | 3.2% | −150.0K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio